Onkologie. 2022:16(6):305-311 | DOI: 10.36290/xon.2022.065

Palliative care in patients with primary brain tumours

Pavel Fadrus1, 3, 5, Ondřej Sláma2, 4, Ludmila Hynková2, 3, 5, Tomáš Kazda3, Radek Lakomý4, Lucie Světláková2, 5, Markéta Hanušová5, Irena Henzlová5, Regina Slámová6, Soňa Kryštofová1, 3, 5, Marek Sova1, 5, Vilém Juráň1, Miloš Duba1, Eduard Neuman1, 3, Pavel Šlampa3, Martin Smrčka1, Václav Vybíhal1, 6
1 Neurochirurgická klinika, Fakultní nemocnice Brno a Lékařské fakulty Masarykovy univerzity, Brno
2 Centrum paliativní medicíny a léčby bolesti, Masarykův onkologický ústav, Brno
3 Klinika radiační onkologie LF MU, Masarykův onkologický ústav, Brno
4 Klinika komplexní onkologické péče, Masarykův onkologický ústav, Brno
5 Dům léčby bolesti s hospicem sv. Josefa, Rajhrad
6 Centrum paliativní péče, Brno

Palliative care (PP) is active multidisciplinary care, which is not primarily aimed at prolonging life or treatment of cancer patients, but at alleviating the symptoms of the underlying disease and thereby improving their quality of life. PP should already be provided during complex oncological care and be an integral part of it. This trend also applies to neuro-oncology patients with a primary brain tumour. Patients with a primary brain tumour do not belong to the most numerous group of oncology patients, but given that, in addition to general symptoms of oncological disease, they are also affected by a progressive neurological disease, they are a specific group of patients. During the care of these patients, PP tries to solve and positively influence not only the symptoms related to the oncological disease, but also includes psychological, social and spiritual care. In the event that the possibilities of oncological antitumor treatment are exhausted, or the treatment is terminated for various reasons, PP becomes the main treatment procedure. For patients with HGG (high grade glioma) - considering the progressive course of this disease - PP should be started immediately after surgery at the same time as the start of their oncological therapy. In patients with LGG (low grade glioma) - when the course of their disease is much more gradual - there are no clear recommendations for the initiation of multidisciplinary PP. This should be indicated and started depending on their current health and psychological state, with the aim of maintaining their good quality of life as long as possible during the course of the disease. The aim of this review article is to provide an overview of the most common symptoms in patients with a primary brain tumour with the possibility of influencing these symptoms within the framework of PP.

Keywords: primary brain tumour, gliomas, palliative care.

Accepted: November 22, 2022; Published: November 22, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fadrus P, Sláma O, Hynková L, Kazda T, Lakomý R, Světláková L, et al.. Palliative care in patients with primary brain tumours. Onkologie. 2022;16(6):305-311. doi: 10.36290/xon.2022.065.
Download citation

References

  1. Louis D, Perry A, Wesseling P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: A Summary. Neuro-Oncology. 2021;23(8):1231-1251. Go to original source... Go to PubMed...
  2. Kiss I, et al. Modrá kniha České onkologické společnosti, 28. aktualizace. Brno: Masarykův onkologický ústav; 2022.
  3. Weller M, van den Bent M, Preusser M, et al. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat. Rev. Clin. Oncol. 2021;18:170-186. Available from: https://doi.org/10.1038/s41571-020-00447-z. Go to original source... Go to PubMed...
  4. IJzerman-Korevaar M, Snijders TJ, de Graeff A, et al. Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review. J Neurooncol. 2018;140:485-496. Available from: https://doi.org/10.1007/s11060-018-03015-9. Go to original source... Go to PubMed...
  5. Koekkoek JAF, Dirven L, Sizoo EM, et al. Symptoms and medication management in the end of life phase of high-grade glioma patients. J. Neurooncol. 2014;120:589-595. Go to original source... Go to PubMed...
  6. Zimmermann C, Riechelmann R, Krzyzanowska M, et al. Effectiveness of specialized palliative care: a systematic review. Jama. 2008;299(14):1698-709. Go to original source... Go to PubMed...
  7. Vecht CJ, Hovestadt A, Verbiest HB, et al. Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day. Neurology. 1994;44(4):675-680. Go to original source... Go to PubMed...
  8. Walbert, T, Chasteen K. Palliative and supportive care for glioma patients. Cancer Treat. Res. 2015;163:171-184. Go to original source... Go to PubMed...
  9. Pompili A, Telera S, Villani V, et a. Home palliative care and end of life issues in glioblastoma multiforme: Results and comments from a homogeneous cohort of patients. Neurosurg. Focus. 2014;37:E5. Go to original source... Go to PubMed...
  10. Dirven L, Sizoo EM, Taphoorn MJ. Anaplastic gliomas: End-of-life care recommendations. CNS Oncol. 2015;4:357-365. Go to original source... Go to PubMed...
  11. Semrad TJ, O'Donnell R, Wun T, et al. Epidemiology of venous thromboembolism in 9489 patients with malignant glioma. J Neurosurg. 2007;106:601-608. Go to original source... Go to PubMed...
  12. Simanek R, Vormittag R, Hassler M, et al. Venous thromboembolism and survival in patients with high-grade glioma. Neuro Oncol. 2007;9:89-95. Go to original source... Go to PubMed...
  13. Pace A, Dirven L, Koekkoek JAF, et al. European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma. Lancet Oncol. 2017;18:e330-e340. Go to original source... Go to PubMed...
  14. Chee CE, Ashrani AA, Marks RS, et al. Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study. Blood. 2014;123(25): 3972-3978. Go to original source... Go to PubMed...
  15. Sizoo EM, Pasman HRW, Dirven L, et al. The end-of-life phase of high-grade glioma patients: A systematic review.Support. Care Cancer. 2014;22:847-857. Go to original source... Go to PubMed...
  16. Ford E, Catt S, Chalmers A, et al. Systematic review of supportive care needs in patients with primary malignant brain tumors. Neuro Oncol. 2012;14:392-404. Go to original source... Go to PubMed...
  17. Acquaye AA, Vera-Bolanos E, Armstrong TS. Mood disturbance in glioma patients.J. Neurooncol. 2013;113:505-512. Go to original source... Go to PubMed...
  18. Rooney A, Grant R. Pharmacological treatment of depression in patients with a primary brain tumour. The Cochrane database of systematic reviews. 2013;3:Cd006932. Go to original source... Go to PubMed...
  19. Ownsworth T, Chambers S, Damborg E, et al. Evaluation of the making sense of brain tumor program: a randomized controlled trial of a home-based psychosocial intervention. Psycho-oncology. 2015;24(5):540-547. Go to original source... Go to PubMed...
  20. Trad W, Koh ES, Daher M, et al. Screening for Psychological Distress in Adult Primary Brain Tumor Patients and Caregivers: Considerations for Cancer Care Coordination. Front. Oncol. 2015;5:3-10. Go to original source... Go to PubMed...
  21. Philip J, Collins A, Brand CA. "I'm just waiting…": An exploration of the experience of living and dying with primary malignant glioma. Support. Care Cancer. 2014;22:389-397. Go to original source... Go to PubMed...
  22. Andrewes HE, Drummond KJ, Rosenthal M, et al. Awareness of psychological and relationship problems amongst brain tumour patients and its association with carer distress. Psychooncology. 2013;22:2200-2205. Go to original source... Go to PubMed...
  23. Poggi G, Liscio M, Pastore V, et al. Massimino, M.Psychological intervention in young brain tumor survivors: The efficacy of the cognitive behavioural approach. Disabil. Rehabil. 2009;31:1066-1073. Go to original source... Go to PubMed...
  24. Robin Grant, Paul DB. Fatigue randomized controlled trials - how tired is "too tired" in patients undergoing glioma treatment? Neuro-Oncology. 2016;18(6):759-760. Go to original source... Go to PubMed...
  25. Attia A, Rapp SR, Case LD, et al. Phase II study of Ginkgo biloba in irradiated brain tumor patients: effect on cognitive function, quality of life, and mood. Journal of neuro-oncology. 2012;109(2):357-363. Go to original source... Go to PubMed...
  26. Boele FW, Douw L, de Groot M, et al. The effect of modafinil on fatigue, cognitive functioning, and mood in primary brain tumor patients: a multicenter randomized controlled trial. Neuro-oncology. 2013;15(10):1420-1428. Go to original source... Go to PubMed...
  27. Catt S, Chalmers A, Fallowfield L. Psychosocial and supportive-care needs in high-grade glioma.Lancet Oncol. 2008;9:884-891. Go to original source... Go to PubMed...
  28. Tucha O, Smely Ch, Preier M, et al. Cognitive Deficits before Treatment among Patients with Brain Tumors, Neurosurgery. 2000;47(2):324-334. Go to original source... Go to PubMed...
  29. Meyers CA, Weitzner MA, Valentine AD, et al. Methylphenidate therapy improves cognition,mood, and function of brain tumor patients. J. Clin. Oncol. 1998;16:2522-2527. Go to original source... Go to PubMed...
  30. Roberts PS, Nuño M, Sherman D, et al. The Impact of Inpatient Rehabilitation on Function and Survival of Newly Diagnosed Patients With Glioblastoma. 2014;6:514-521. Go to original source... Go to PubMed...
  31. Pace A, Villani V, Di Pasquale A, et al. Home care for brain tumor patients. Neuro-oncology practice. 2014;1(1):8-12. Go to original source... Go to PubMed...
  32. Formica V, Del Monte G, Giacchetti I, et al. Rehabilitation in neuro-oncology: a meta-analysis of published data and a mono-institutional experience. Integrative cancer therapies. 2011;10(2):119-126. Go to original source... Go to PubMed...
  33. Kirste S, Treier, M, Wehrle SJ, et al. Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors. Cancer. 2011;117:3788-3795. Available from: https://doi.org/10.1002/cncr.25945. Go to original source... Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.